What is the debt of Orgenesis this year?
Orgenesis has a debt level of 21.47 USD this year.
Orgenesis Debt 2024
Orgenesis Debt
21.47 USD
Ticker
ORGS
ISIN
US68619K2042
WKN
A2H7XQ
In 2024, Orgenesis's total debt was 21.47 USD, a 69.2% change from the 12.69 USD total debt recorded in the previous year.
Orgenesis Aktienanalyse
What does Orgenesis do?
Orgenesis Inc is a company specializing in the development of therapies for the treatment of diabetes and other diseases. The company was founded in 2008 to advance research on new therapy approaches for diabetes treatment. Its business model is based on the development of cell therapy technologies to treat patients with diabetes. The company focuses on developing therapies that use human cells to regulate the body's immune system and improve insulin production. Orgenesis Inc also offers consulting services to help other companies develop similar technologies. The company's goal is to provide technology and know-how to drive industrial progress and help people worldwide. Orgenesis Inc is divided into several areas, including biotherapeutics, where it researches and develops therapeutic cell therapies for diabetes and other chronic diseases. It also operates in the engineering services sector, assisting with the design, construction, and development of other therapies and medical devices. The company also distributes products for monitoring diabetes in patients, such as innovative devices that monitor blood glucose and other important parameters, triggering alarms when certain thresholds are exceeded. In summary, Orgenesis Inc is a leading company in the research and development of cell therapy technologies in the field of diabetes and autoimmune therapy. It engages in a wide range of activities, from consulting services to engineering tasks and marketing its own products. This "closed loop" approach of research, development, and marketing has made Orgenesis Inc an innovative company that plays a significant role in the global healthcare industry. Orgenesis ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Orgenesis's Debt Structure
Orgenesis's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Orgenesis's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Orgenesis’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Orgenesis’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Orgenesis stock
What was the debt of Orgenesis compared to the previous year?
The debt of Orgenesis has increased by 69.2% compared to the previous year increased.
What are the consequences of high debt for investors in Orgenesis?
High debt can pose a risk for investors of Orgenesis, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Orgenesis?
Low debt means that Orgenesis has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Orgenesis affect the company?
An increase in debt of Orgenesis can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Orgenesis affect the company?
A reduction in debt of Orgenesis can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Orgenesis?
Some factors that can influence the debt of Orgenesis include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Orgenesis so important for investors?
The debts of Orgenesis are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Orgenesis take to change the debt?
To change the debt, Orgenesis can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Orgenesis pay?
Over the past 12 months, Orgenesis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Orgenesis is expected to pay a dividend of 0 USD.
What is the dividend yield of Orgenesis?
The current dividend yield of Orgenesis is .
When does Orgenesis pay dividends?
Orgenesis pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Orgenesis?
Orgenesis paid dividends every year for the past 0 years.
What is the dividend of Orgenesis?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Orgenesis located?
Orgenesis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orgenesis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orgenesis from 9/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/7/2024.
When did Orgenesis pay the last dividend?
The last dividend was paid out on 9/7/2024.
What was the dividend of Orgenesis in the year 2023?
In the year 2023, Orgenesis distributed 0 USD as dividends.
In which currency does Orgenesis pay out the dividend?
The dividends of Orgenesis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orgenesis
Our stock analysis for Orgenesis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orgenesis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
